Drug Safety Update – Atypical femoral fractures with Bisphosphonates

Drug Safety Update – Atypical femoral fractures with Bisphosphonates

Atypical femoral fractures have been reported rarely with bisphosphonate therapy, mainly in patients receiving long-term treatment for osteoporosis. Discontinuation of bisphosphonate therapy in patients suspected to have an atypical femur fracture should be considered while they are evaluated, and should be based on an assessment of the

Read more

ONtrack

ONtrack

Tomorrow’s Pharmacist (1) has launched a website called ONtrack (2) to support preregistration trainees’ revision for the registration exam. There are section for open book, closed book and calculation elements of the exam. It will cost Royal Pharmaceutical Society’s associate members £25 and £35 for non-members.

Read more